Dr. Diana Brixner is currently Professor in the Department of Pharmacotherapy and serves as the Executive Director of the Pharmacotherapy Outcomes Research Center at the University of Utah in Salt Lake City, UT. She holds two adjunct positions in the School of Medicine in the Department of Population Health Sciences and Department of Pediatrics, Division of Clinical Pharmacology. She is a member of the Huntsman Cancer Institute Cancer Control and Population Sciences and the Center for Genomic Medicine.
Dr. Brixner was a Past President for both the Academy of Managed Care Pharmacy (AMCP) and International Society of Pharmacoeconomics and Outcomes Research (ISPOR). She was recently a one-year Scholar-in-Residence for the Academy of Managed Care Pharmacy. Education & Training: Dr. Brixner received her B.S. degree in 1982 from the University of Rhode Island, Pharmacy. In 1987 she received her Ph.D. in Medicinal Chemistry from the University of Utah. She received a Modeling Approaches for Health Technology Assessment Certificate in 2010, a Clinical Epidemiology Certificate in 2013 and a Certificate in the Introduction to Health Technology Assessment in 2015 from the University of Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria where she spent a sabbatical in 2011.
Dr. Brixner's research focus is on the design, conduct, and communication of pharmacoeconomic and outcomes research studies to demonstrate the value of pharmaceutical and related therapies from the perspective of the private and public payer. She has published over 150 articles in peer-reviewed journals, authored three book chapters, has one issued patent, and has been an invited speaker at a variety of national and international professional meetings.